JADPRO Live 2019 Activities
JADPRO Live 2018 Activities
MPN Resource Center
Myelofibrosis: Narratives on Collaboration
Relapsed/Refractory Multiple Myeloma
Management of irAEs
Managing Classical Hodgkin Lymphoma
Updates in Heme Malignancy Side Effects
Narratives: HER2-Positive Breast Cancer
Learn more on this topic:
New Drug Updates in Solid Tumors: PARP Inhibitors in Ovarian Cancer, Immunotherapeutics, and Other Agents
What are the signs and symptoms of serious adverse effects linked with newly approved solid tumor drugs?
Edward Li, PharmD, MPH, BCOP
Edward Li, PharmD, MPH, BCOP, on solid tumors: new drug approvals.
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.